| Literature DB >> 27537182 |
Xiaofeng Wang1, Yu Wang2, Lingfang Feng2, Yan Tong2, Zhijian Chen2, Shibo Ying2, Tianhui Chen2, Tao Li2, Hailing Xia2, Zhaoqiang Jiang2, Qi Shang3, Xiaoming Lou1, Jianlin Lou2.
Abstract
The benchmark dose (BMD) method has been increasingly used to assess the health risks of cadmium (Cd) in epidemiological studies. The aim of our study was to estimate the threshold levels of urinary Cd (UCd) using the BMD method in a general population of Jiangshan City, Zhejiang Province of China. In our study, a total of 934 people (469 men, 465 women) were recruited and morning urine samples were collected from all the participants. Levels of Cd, creatinine, and renal dysfunction indicators such as retinol binding protein (RBP), β2-microglobulin (β2-MG), and N-acetyl-b-glucosaminidase (NAG) in urine were detected for analysis of BMD and BMD low (BMDL) of UCd. RBP, β2-MG, and NAG in urine all correlated significantly (P < 0.001) with UCd except of age (P = 0.767). When the benchmark response (BMR) was 5%, the BMD/BMDL of UCd for RBP, β2-MG, and NAG was 1.69/ 0.89, 1.24/0.62, 0.85/0.49 μg/g Cr in men and 1.70/0.76, 1.35/0.64, 1.36/0.65 μg/g Cr in women, respectively. If the BMR was set at 10%, the BMD/BMDL of UCd for RBP, β2-MG, and NAG was 2.44/1.59, 2.09/1.30, 1.80/1.04 μg/g Cr in men and 2.43/1.53, 2.10/1.34, 2.31/1.37 μg/g Cr in women, respectively. Our results provided evidence for Cd-induced tubular effects in cadmium non-polluted areas in China. Both β2-MG and NAG were more sensitive than RBP in response to Cd exposure. But β2-MG was the most sensitive indicator in women, and NAG was the most sensitive one in men.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27537182 PMCID: PMC4990304 DOI: 10.1371/journal.pone.0161240
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Age distribution of subjects enrolled in our study.
| Age (years) | Male | Female |
|---|---|---|
| < = 10 | 60 | 54 |
| 11–20 | 96 | 94 |
| 21–30 | 53 | 55 |
| 31–40 | 49 | 47 |
| 41–50 | 54 | 57 |
| 51–60 | 56 | 55 |
| 61–70 | 48 | 55 |
| 71+ | 53 | 48 |
| Total | 469 | 465 |
Cut-off values of URBP, Uβ-MG, and UNAG.
| Indexes | Unit | Sex | Cut-off value | |
|---|---|---|---|---|
| 90% | 95% | |||
| RBP | μg/g Cr | Male | 272.92 | 542.08 |
| Female | 227.00 | 498.66 | ||
| mg/g Cr | Male | 0.78 | 1.39 | |
| Female | 0.69 | 1.77 | ||
| NAG | U/g Cr | Male | 16.49 | 25.93 |
| Female | 17.82 | 24.81 | ||
Cut-off values are defined as the 90% or 95% upper limit values, which are calculated from the 934 persons who participated in this study.
Fig 1Correlations among age, three biomarkers (RBP, β2-MG, and NAG), and urinary Cd.
r, correlation coefficient.
Prevalence of hyper-URBP at different levels of urinary Cd in males and females living in a Cd non-polluted area in China.
| UCd (μg/g Cr) | Cut-off (90%) | Cut-off (95%) | ||||
|---|---|---|---|---|---|---|
| Range | GM | Total number | n | % | n | % |
| < = 0.49 | 0 | 159 | 14 | 8.8 | 5 | 3.1 |
| 0.50–0.99 | 0.69 | 127 | 5 | 3.9 | 5 | 3.9 |
| 1.00–1.49 | 1.20 | 62 | 9 | 14.5 | 7 | 11.3 |
| 1.50–1.99 | 1.67 | 24 | 3 | 12.5 | 2 | 8.3 |
| 2.00+ | 3.43 | 35 | 8 | 22.9 | 1 | 2.9 |
| Total | 407 | 39 | 9.6 | 20 | 4.9 | |
| Linear trend test | χ2 = 7.106, | χ2 = 1.335, | ||||
| < = 0.49 | 0 | 127 | 7 | 5.5 | 2 | 1.6 |
| 0.50–0.99 | 0.70 | 123 | 8 | 6.5 | 3 | 2.4 |
| 1.00–1.49 | 1.20 | 57 | 4 | 7 | 3 | 5.3 |
| 1.50–1.99 | 1.74 | 35 | 4 | 11.4 | 3 | 8.6 |
| 2.00+ | 3.53 | 59 | 14 | 23.7 | 8 | 13.6 |
| Total | 401 | 37 | 9.2 | 19 | 4.7 | |
| Linear trend test | χ2 = 14.718, | χ2 = 14.547, | ||||
UCd, Urinary cadmium concentration; GM, geometric mean; n, number of subjects with hyper-URBP; %, prevalence of hyper-URBP. Cut-off (90%) or (95%), Cut-off values of URBP are 90% or 95% upper limit values calculated from 469 men and 465 women.
Prevalence of hyper-UNAG at different levels of urinary Cd in males and females living in a Cd non-polluted area in China.
| UCD (μg/g Cr) | Total number | Cut-off (90%) | Cut-off (95%) | |||
|---|---|---|---|---|---|---|
| Range | GM | N | % | N | % | |
| < = 0.49 | 0 | 164 | 9 | 5.5 | 2 | 1.2 |
| 0.50–0.99 | 0.69 | 133 | 11 | 8.3 | 5 | 3.8 |
| 1.00–1.49 | 1.20 | 68 | 13 | 19.1 | 6 | 8.8 |
| 1.50–1.99 | 1.67 | 26 | 4 | 15.4 | 3 | 11.5 |
| 2.00+ | 3.43 | 38 | 6 | 15.8 | 4 | 10.5 |
| Total | 429 | 43 | 10 | 20 | 4.7 | |
| Linear trend test | χ2 = 10.075, | χ2 = 11.822, | ||||
| < = 0.49 | 0 | 136 | 10 | 7.4 | 3 | 2.2 |
| 0.50–0.99 | 0.70 | 131 | 9 | 6.9 | 4 | 3.1 |
| 1.00–1.49 | 1.20 | 62 | 7 | 11.3 | 2 | 3.2 |
| 1.50–1.99 | 1.74 | 38 | 7 | 18.4 | 5 | 13.2 |
| 2.00+ | 3.53 | 62 | 13 | 21 | 7 | 11.3 |
| Total | 429 | 46 | 10.7 | 21 | 4.9 | |
| Linear trend test | χ2 = 11.241, | χ2 = 11.227, | ||||
UCD, Urinary cadmium concentration; GM, geometric mean; n, number of subjects with hyper-UNAG; %, prevalence of hyper-UNAG. Cut-off (90%) or (95%), Cut-off values of UNAG are 90% or 95% upper limit values calculated from 469 men and 465 women.
BMDL estimates of urinary Cd for URBP, Uβ-MG, and UNAG.
| Indicators | Sex | Cut-off values (%) | AIC | Intercept | Slope | BMD10 | BMDL10 | BMD05 | BMDL05 | |
|---|---|---|---|---|---|---|---|---|---|---|
| RBP | Males | 90 | 255.32 | -4.02 | 2.04 | 0.07 | 2.44 | 1.59 | 1.69 | 0.89 |
| Females | 90 | 238.14 | -4.06 | 2.10 | 0.95 | 2.43 | 1.53 | 1.70 | 0.76 | |
| Males | 90 | 251.52 | -3.26 | 1.44 | 0.31 | 2.09 | 1.30 | 1.24 | 0.62 | |
| Females | 90 | 247.49 | -3.45 | 1.68 | 0.43 | 2.10 | 1.34 | 1.35 | 0.64 | |
| NAG | Males | 90 | 275.70 | -2.80 | 1.00 | 0.24 | 1.8 | 1.04 | 0.85 | 0.49 |
| Females | 90 | 288.80 | -3.37 | 1.40 | 0.46 | 2.31 | 1.37 | 1.36 | 0.65 |
BMD10, Excess risk at BMR of 0.10; BMD5, Excess risk at BMR of 0.05; Cut-off (90%), Cut-off values are 90% upper limit values calculated from 469 men and 465 women.
Prevalence of hyper-Uβ-MG at different levels of urinary Cd in males and females living in a Cd non-polluted area in China.
| UCD (μg/g Cr) | Total number of subjects | Cut-off (90%) | Cut-off (95%) | |||
|---|---|---|---|---|---|---|
| Range | GM | N | % | N | % | |
| < = 0.49 | 0 | 163 | 10 | 6.1 | 5 | 3.1 |
| 0.50–0.99 | 0.69 | 131 | 7 | 5.3 | 2 | 1.5 |
| 1.00–1.49 | 1.20 | 66 | 9 | 13.6 | 6 | 9.1 |
| 1.50–1.99 | 1.67 | 26 | 4 | 15.4 | 1 | 3.8 |
| 2.00+ | 3.43 | 38 | 8 | 21.1 | 4 | 10.5 |
| Total | 424 | 38 | 9.0 | 18 | 4.2 | |
| Linear trend test | χ2 = 12.060, | χ2 = 5.387, | ||||
| < = 0.49 | 0 | 133 | 6 | 4.5 | 1 | 0.8 |
| 0.50–0.99 | 0.70 | 130 | 9 | 6.9 | 4 | 3.1 |
| 1.00–1.49 | 1.20 | 60 | 3 | 5.0 | 2 | 3.3 |
| 1.50–1.99 | 1.74 | 38 | 6 | 15.8 | 3 | 7.9 |
| 2.00+ | 3.53 | 62 | 15 | 24.2 | 10 | 16.1 |
| Total | 423 | 39 | 9.2 | 20 | 4.7 | |
| Linear trend test | χ2 = 19.479, | χ2 = 21.309, | ||||
UCD, Urinary cadmium concentration; GM, geometric mean; n, number of subjects with hyper-Uβ-MG; %, prevalence of hyper-Uβ-MG. Cut-off (90%) or (95%), Cut-off values of Uβ-MG are 90% or 95% upper limit values calculated from 469 men and 465 women.